Who owns Niagen Bioscience, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NAGE from SEC Form 13F filings across 140 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 140 institutions disclosed 32.4M shares of Niagen Bioscience, Inc. worth $96.5M — about 40.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
140
13F holders
$96.5M
value, 2026 filers
40.8%
of shares outstanding (32.4M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NAGE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.2M | $13.3M | 0.0% | 5.3% | +8.1% |
| 2 | SteelPeak Wealth, LLC | 3.5M | $11.2M | 0.3% | 4.4% | +3.8% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $6.8M | 0.0% | 2.7% | -0.1% |
| 4 | Tieton Capital Management, LLC | 2.0M | $6,407 | 0.0% | 2.5% | -1.0% |
| 5 | Qube Research & Technologies Ltd | 1.6M | $5.2M | 0.0% | 2% | -5.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $4.7M | 0.0% | 1.9% | +9.9% |
| 7 | UBS Group AG | 1.3M | $4.1M | 0.0% | 1.6% | -8.7% |
| 8 | GOLDMAN SACHS GROUP INC | 1.3M | $4.0M | 0.0% | 1.6% | +0.9% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.2M | $3.7M | 0.0% | 1.5% | -50.8% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2M | $3.7M | 0.0% | 1.5% | -4.5% |
| 11 | STATE STREET CORP | 1.1M | $3.5M | 0.0% | 1.4% | -0.2% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 659,584 | $2.1M | 0.0% | 0.8% | -50.4% |
| 13 | CITADEL ADVISORS LLC | 630,109 | $2.0M | 0.0% | 0.8% | +18.8% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 605,326 | $1.9M | 0.0% | 0.8% | -43.5% |
| 15 | MORGAN STANLEY | 504,772 | $1.6M | 0.0% | 0.6% | +32.5% |
| 16 | VICTORY CAPITAL MANAGEMENT INC | 473,372 | $1.5M | 0.0% | 0.6% | +11.3% |
| 17 | AQR CAPITAL MANAGEMENT LLC | 472,056 | $1.5M | 0.0% | 0.6% | -54.2% |
| 18 | SEI INVESTMENTS CO | 471,934 | $1.5M | 0.0% | 0.6% | -51.4% |
| 19 | NORTHERN TRUST CORP | 466,720 | $1.5M | 0.0% | 0.6% | +17.8% |
| 20 | Connor, Clark & Lunn Investment Management Ltd. | 458,614 | $1.5M | 0.0% | 0.6% | -21.3% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 431,614 | $1.4M | 0.0% | 0.5% | -3.5% |
| 22 | Sixth Street Partners Management Company, L.P.NEW | 431,614 | $1.4M | 0.2% | 0.5% | new |
| 23 | VANGUARD FIDUCIARY TRUST CO | 400,253 | $1.3M | 0.0% | 0.5% | +6.9% |
| 24 | PANAGORA ASSET MANAGEMENT INC | 347,207 | $1.1M | 0.0% | 0.4% | +96.2% |
| 25 | JPMORGAN CHASE & CONEW | 333,204 | $1.1M | 0.0% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.